Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54.2K Buy
17,268
+513
+3% +$1.6K 0.02% 198
2026
Q1
$48.9K Buy
16,755
+2,875
+21% +$8.21K 0.02% 185
2025
Q4
$34.3K Sell
13,880
-502
-3% -$1.2K 0.01% 187
2025
Q3
$32.1K Sell
14,382
-2,942
-17% -$6.73K 0.01% 173
2025
Q2
$41.8K Buy
17,324
+6,868
+66% +$16.7K 0.02% 138
2025
Q1
$24.4K Sell
10,456
-1,928
-16% -$3.86K 0.01% 147
2024
Q4
$22.9K Sell
12,384
-5,370
-30% -$11.9K 0.01% 140
2024
Q3
$43.3K Buy
17,754
+6,171
+53% +$13.8K 0.02% 131
2024
Q2
$23.7K Buy
+11,583
New +$26.4K 0.01% 130

Other funds holding ABEV

Traveka Wealth's ABEV Position: Q2 2026 in Review

Traveka Wealth increased its Ambev (ABEV) stake by 3.1% in Q2 2026, buying an estimated $1.6K and bringing the position to 17,268 shares worth $54.2K. The position accounts for 0.02% of the portfolio, ranked #198.

Traveka Wealth first reported a position in ABEV in Q2 2024 and has held it in 9 quarters since. 154 funds tracked by Wall St. Rank hold ABEV as of Q2 2026.

  • Traveka Wealth held 17,268 shares of Ambev worth $54.2K as of Q2 2026.
  • Traveka Wealth bought 513 Ambev shares in Q2 2026, an estimated $1.6K.
  • Ambev made up 0.02% of Traveka Wealth's portfolio in Q2 2026, its #198 holding.
  • Traveka Wealth first reported a position in Ambev in Q2 2024 and has held it in 9 quarters since.
  • 154 funds tracked by Wall St. Rank held Ambev as of Q2 2026.

Based on Traveka Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.